| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |